These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27089090)

  • 1. ACP Journal Club. Review: In HF with reduced EF, nurse-led titration of HF drugs reduces hospitalizations and mortality.
    Shah T; Deswal A
    Ann Intern Med; 2016 Apr; 164(8):JC41. PubMed ID: 27089090
    [No Abstract]   [Full Text] [Related]  

  • 2. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.
    Driscoll A; Currey J; Tonkin A; Krum H
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009889. PubMed ID: 26689943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol.
    Oyanguren J; García-Garrido L; Nebot Margalef M; Lekuona I; Comin-Colet J; Manito N; Roure J; Ruiz Rodriguez P; Enjuanes C; Latorre P; Torcal Laguna J; García-Gutiérrez S;
    ESC Heart Fail; 2017 Nov; 4(4):507-519. PubMed ID: 29154427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nurse-Led Titration of Angiotensin-Converting Enzyme Inhibitors, β-Adrenergic Blocking Agents, and Angiotensin Receptor Blockers in Patients With Heart Failure With Reduced Ejection Fraction.
    Driscoll A; Currey J; Tonkin AM
    JAMA Cardiol; 2016 Oct; 1(7):842-843. PubMed ID: 27556747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher medication doses in heart failure?
    McCormack J; McAlister FA; Kolber MR
    Can Fam Physician; 2017 Jan; 63(1):e20. PubMed ID: 28115456
    [No Abstract]   [Full Text] [Related]  

  • 6. Implementation of a pharmacist-managed heart failure medication titration clinic.
    Martinez AS; Saef J; Paszczuk A; Bhatt-Chugani H
    Am J Health Syst Pharm; 2013 Jun; 70(12):1070-6. PubMed ID: 23719886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF.
    Ouwerkerk W; Zwinderman AH; Ng LL; Demissei B; Hillege HL; Zannad F; van Veldhuisen DJ; Samani NJ; Ponikowski P; Metra M; Ter Maaten JM; Lang CC; van der Harst P; Filippatos G; Dickstein K; Cleland JG; Anker SD; Voors AA
    J Am Coll Cardiol; 2018 Jan; 71(4):386-398. PubMed ID: 29389354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Intensive Nurse-Led Optimization of Heart Failure Medications in Patients With Heart Failure: A Meta-analysis of Randomized Controlled Trials.
    Driscoll A; Meagher S; Kennedy R; Currey J
    J Cardiovasc Nurs; 2024 Sep-Oct 01; 39(5):417-426. PubMed ID: 38227630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Stepwise Approach to the Management of Heart Failure and its Comorbidities.
    Rogers FJ; Saghir Z
    J Am Osteopath Assoc; 2020 Feb; 120(2):90-99. PubMed ID: 31985768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.
    Tavazzi L; Maggioni AP; Borer JS
    Eur Heart J; 2013 Sep; 34(36):2792-4. PubMed ID: 23892200
    [No Abstract]   [Full Text] [Related]  

  • 11. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
    Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Male-female differences in the optimal dosage of medication for heart failure; the 'one-size-fits-all' approach to guidelines needs revision].
    Groenewegen A; Mosterd A; Rutten FH
    Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32391993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.
    Krum H; Shi H; Pitt B; McMurray J; Swedberg K; van Veldhuisen DJ; Vincent J; Pocock S; Zannad F;
    Circ Heart Fail; 2013 Jul; 6(4):711-8. PubMed ID: 23625945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of oral chronic pharmacotherapy in patients hospitalized for acute decompensated heart failure.
    Piepoli M; Binno S; Villani GQ; Cabassi A
    Int J Cardiol; 2014 Sep; 176(2):321-6. PubMed ID: 25129309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
    Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
    JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart Failure Due to Reduced Ejection Fraction: Medical Management.
    Chavey WE; Hogikyan RV; Van Harrison R; Nicklas JM
    Am Fam Physician; 2017 Jan; 95(1):13-20. PubMed ID: 28075105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial pharmacological treatment of the patient with heart failure with reduced systolic function: is the order of the initial and subsequent doses important?].
    Formiga F; Nuñez J
    Rev Esp Geriatr Gerontol; 2018; 53(4):183-184. PubMed ID: 29887284
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.
    Willenheimer R; van Veldhuisen DJ; Ponikowski P; Lechat P;
    J Am Coll Cardiol; 2005 Jul; 46(1):182. PubMed ID: 15992659
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function.
    Law Y
    J Am Coll Cardiol; 2005 Jul; 46(1):181-2; author reply 183. PubMed ID: 15992657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.